630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
650 812 8700
https://www.affymax.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 2
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Mark G. Thompson | CFO & Secretary | 97.49k | N/D | 1962 |
Mr. Jonathan M. Couchman | CEO, President & Director | N/D | N/D | 1970 |
Dr. Tracy J. Dunn Ph.D., J.D. | Vice President of Intellectual Property & Legal Affairs | N/D | N/D | 1963 |
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
La calificación ISS Governance QuickScore de Affymax, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.